Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction

American Journal of Cardiology

Volumn 81, Issue 12, 1998, Pages 1491-1493

  Miller, Todd D ^a   Hodge, David O ^b   Sutton, Joseph M ^b   Grines, Cindy L ^b   O'Keefe, James H ^b   DeWood, Marcus A ^b   Okada, Robert D ^b   Fletcher Jr , William O ^b   Gibbons, Raymond J ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 0032525817     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00220-3     Document Type: Article

References (6)

1. 99mTc-hexakis-2 methoxy-2 methylpropy-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277-1286.
2. 2. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;82:81-90.
3. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-341.
4. 4. O'Connor MK, Hammell TC, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percent myocardium "at risk" following administration of Tc 99m isonitrile. Eur J Nucl Med 1990;17:69-76.
5. 5. Medrano R, Lowry RW, Young JB, Weilbaccher DG, Michael LH, Afridi I, He X, Mahmarian JJ, Verani MS. Assessment of myocardial viability with technetium-99m sestamibi in patients undergoing cardiac transplantation. A scintigraphic pathological study. Circulation 1996;94:1010-1017.
6. 6. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wassermann A, Robertson T, Ross R, and TIMI Investigators. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) phase II trial. Circulation 1992;85:533-542.